Intramyocardial Implantation of CD133 + Stem Cells Improved Cardiac Function without Bypass Surgery

Abstract

CD133+ injection into ischemic myocardium was feasible and safe. Stem cell transplantation alone improved cardiac function in all patients. This technique might hold promise as an alternative to medical management in patients with severe ischemic heart failure who are ineligible for conventional revascularization.